{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:43:33Z","timestamp":1791855813044,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/7\/1090\/2013-RHN"],"award-info":[{"award-number":["5\/7\/1090\/2013-RHN"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2017-2023"],"award-info":[{"award-number":["2017-2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["CTRI\/2015\/07\/006002"],"award-info":[{"award-number":["CTRI\/2015\/07\/006002"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.kint.2024.01.028","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T11:37:20Z","timestamp":1707824240000},"page":"1113-1123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome"],"prefix":"10.1016","volume":"105","author":[{"given":"Aditi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshetrimayum Ghanapriya","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprita","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalaivani","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.01.028_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","article-title":"Steroid sensitive nephrotic syndrome: revised guidelines","volume":"58","author":"Sinha","year":"2021","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.kint.2024.01.028_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","article-title":"Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Gulati","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/adc.2007.116079","article-title":"Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial","volume":"93","author":"Abeyagunawardena","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.kint.2024.01.028_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000045684","article-title":"Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome","volume":"85","author":"Mattoo","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2024.01.028_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamapediatrics.2021.5189","article-title":"Evaluation of daily low-dose prednisolone during upper respiratory tract infection to prevent relapse in children with relapsing steroid-sensitive nephrotic syndrome: the PREDNOS 2 randomized clinical trial","volume":"176","author":"Christian","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.kint.2024.01.028_bib7","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement","volume":"308","author":"Piaggio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.01.028_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib9","author":"World Health Organization"},{"key":"10.1016\/j.kint.2024.01.028_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/2230-8210.159028","article-title":"Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5-18-year-old Indian children","volume":"19","author":"Khadilkar","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.kint.2024.01.028_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13312-019-1461-2","article-title":"Height velocity percentiles in Indian children aged 5\u201317 years","volume":"56","author":"Khadilkar","year":"2019","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.kint.2024.01.028_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"suppl 27","key":"10.1016\/j.kint.2024.01.028_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pedi.12773","article-title":"ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"19","author":"Mayer-Davis","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.kint.2024.01.028_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","article-title":"Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"34","author":"Yadav","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13312-014-0419-7","article-title":"Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome","volume":"51","author":"Ekambaram","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.kint.2024.01.028_bib18","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.kint.2018.08.039","article-title":"Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open label randomized controlled trial","volume":"95","author":"Sinha","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.028_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00467-017-3640-5","article-title":"Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome","volume":"32","author":"Abeyagunawardena","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib20","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00467-022-05483-8","article-title":"Rates of idiopathic childhood nephrotic syndrome relapse are lower during the COVID-19 pandemic","volume":"37","author":"Crane","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib21","first-page":"CD002290","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"4","author":"Larkins","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2024.01.028_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","article-title":"A\u00a0randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome","volume":"93","author":"Gruppen","year":"2018","journal-title":"Kidney Int"},{"issue":"suppl 3","key":"10.1016\/j.kint.2024.01.028_bib23","first-page":"i806","article-title":"FC038: efficacy of levamisole for maintaining remission after the first flare of steroid sensitive nephrotic syndrome in children: the nephrovir-3 randomized controlled trial","volume":"37","author":"Dossier","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.01.028_bib24","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ekir.2019.08.019","article-title":"Steroid-associated side effects in patients with primary proteinuric kidney disease","volume":"4","author":"Oh","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.01.028_bib25","first-page":"860","article-title":"Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects","volume":"8","author":"M\u00fchlig","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.kint.2024.01.028_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/ijd.14249","article-title":"Antineutrophil cytoplasmic antibodies negative levamisole-induced leukocytoclastic vasculitis: a presumed case and literature review","volume":"57","author":"Kunzler","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.kint.2024.01.028_bib27","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00467-020-04915-7","article-title":"Levamisole and ANCA positivity\u00a0in childhood nephrotic syndrome","volume":"36","author":"Krischock","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00467-022-05547-9","article-title":"Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C","volume":"37","author":"Veltkamp","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.028_bib29","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1007\/s00467-021-05231-4","article-title":"The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndrome","volume":"36","author":"Hoogenboom","year":"2021","journal-title":"Pediatr Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:27:43Z","timestamp":1778664463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0085253824000899"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}